Dr. Michel-Ange Camille, MD

Dr. Camille practices at St. John's Riverside Hospital in Yonkers, New York, part of St. John's Riverside Hospital.

Dr. Camille's NPI, 1164452009, was assigned on July 4, 2006. Dr. Camille holds New York license 155458.

Dr. Camille's primary practice is St. John's Riverside Hospital, at 976 North Broadway, Yonkers, NY 10701 in Westchester County. The practice phone is (914) 964-4444. Dr. Camille also practices at St Johns Riverside Hospital - Andrus Pavillion, 967 N Broadway, Yonkers, NY 10701.

Dr. Camille's primary practice is St. John's Riverside Hospital in Yonkers, New York, part of St. John's Riverside Hospital. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Camille to 3 more group practices and clinics, 2 medical groups and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Camille practices, 5 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Camille's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Camille is licensed in New York.

CMS data shows 77 Medicare services from Dr. Camille across 1 procedure code in 2024, for 64 Medicare patients. Medicare paid $12,107 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 64 Medicare patients who saw Dr. Camille in 2024. The largest group is under 65, with 37 patients. 75% of them have alcohol and drug use disorders, and 75% have anxiety. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Camille's median patient age at 66, with 22% women.

In 2024, Dr. Camille wrote 67 Medicare Part D claims for 35 patients. 99% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $68 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Camille for performance year 2024, reported as part of a group.

CMS Open Payments shows 18 general payments to Dr. Camille from 7 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $114.